ArticleOpen forum infectious diseases2026
Clinical and Molecular Characteristics of
Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Method: We retrospectively analyzed 73 consecutive episodes of SDSE bacteremia, including 63 initial and 10 recurrent episodes, from April 2020 through September 2024. Clinical features were compared with those of Results: The median age of patients with initial SDSE bacteremia was 86.0 years, the highest among 10 major bloodstream pathogens evaluated, predominantly affecting super-elderly patients compared with GAS and GBS. Lower-extremity skin and soft tissue infections were the most common portal of entry. Among 10 recurrent episodes, 5 were caused by strains with STs and Conclusions: In our cohort, SDSE bacteremia predominantly affected super-elderly adults and frequently arose from lower-extremity portals of entry. Recurrent episodes involved both probable relapse and potential reinfection. These findings suggest that localized interventions, such as skin care and edema management, may be important adjuncts to antimicrobial therapy for preventing recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.